Icon

Fotivda - (0.89 and 1.34 mg ; Capsules)

Tivozanib Hydrochloride Aveo Pharmaceuticals INC
0.89 and 1.34 mg ; Capsules
Less Than $1000 mn
None None
Less Than 5
None
None None
FOTIVDA is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
Yes
Fotivda Patent 1 Patent 2 Patent 3
******* *******
  1. *** **, **** : * **** ** ** ***** *** ***** *** ***** ****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.